PlumX Metrics
Embed PlumX Metrics

Apolipoprotein E, amyloid-β, and blood-brain barrier permeability in Alzheimer disease

Journal of Neuropathology and Experimental Neurology, ISSN: 0022-3069, Vol: 67, Issue: 4, Page: 261-270
2008
  • 86
    Citations
  • 0
    Usage
  • 105
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Review Description

There is increasing evidence for blood-brain barrier (BBB) compromise in Alzheimer disease (AD). The presence of the ε4 allele of the apolipoprotein E (apoE) gene is a risk factor for sporadic AD. Apolipoprotein E is essential both for maintenance of BBB integrity and for the deposition of fibrillar amyloid-β (Aβ) that leads to the development of Aβ plaques in AD and to cerebral amyloid angiopathy. This review investigates the relationships between apoE, Aβ, and the BBB in AD. Alterations in the expression and distribution of the BBB Aβ transporters receptor for advanced glycation end-products and low-density lipoprotein receptor-related protein 1 in AD and the potential roles of apoE4 expression in adversely influencing Aβ burden and BBB permeability are also examined. Because both apoE and Aβ are ligands for low-density lipoprotein receptor-related protein 1, all 3 molecules are present in AD plaques, and most AD plaques are located close to the cerebral microvasculature. The interactions of these molecules at the BBB likely influence metabolism and clearance of Aβ and contribute to AD pathogenesis. Therapeutic alternatives targeting apoE/Aβ and sealing a compromised BBB are under development for the treatment of AD. © 2008 American Association of Neuropathologists, Inc.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know